Aplex Bio
PrivateLast Round
Grant
Nov 2, 2023
Total Funding Raised
$1.45M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aplex Bio is a biotechnology company that develops hyperplexed PCR solutions for the detection of multiple biomarkers in a single sample.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aplex Bio Comparables
Compare Aplex Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Signal Bioscience | 78% | |
| ChromaCode | 78% | |
| YouSeq | 71% |
Aplex Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 2, 2023 | ||||
| Seed | Mar 11, 2022 |
Aplex Bio Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 954% to 3.7K.
- May 15, 2026
Monthly visitors grew 41% MoM, reaching 2K.
Aplex Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aplex Bio's valuation, stock price, and market status.
Is Aplex Bio a public or private company?
Aplex Bio is a private company.
What is the current stock price of Aplex Bio?
Aplex Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Aplex Bio worth (valuation)?
Valuation information for Aplex Bio is not publicly available.
Can I buy Aplex Bio stock?
Aplex Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aplex Bio's last funding round?
Aplex Bio's most recent funding round was Grant on November 2, 2023.
Who are the main investors in Aplex Bio?
Key investors in Aplex Bio include Vinnova, NOME.
Will Aplex Bio IPO soon?
No public IPO plans have been announced for Aplex Bio.
How can I track Aplex Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aplex Bio's secondary market activity and sign up for updates.